HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11

HC Wainwright & Co. analyst Arthur He has maintained a Buy rating on Satellos Bioscience (NASDAQ: MSLE) and raised the price target significantly from $1.20 to $11. This adjustment reflects a positive outlook for the company.